These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18201064)

  • 1. Binding of serotonin and N1-benzenesulfonyltryptamine-related analogs at human 5-HT6 serotonin receptors: receptor modeling studies.
    Dukat M; Mosier PD; Kolanos R; Roth BL; Glennon RA
    J Med Chem; 2008 Feb; 51(3):603-11. PubMed ID: 18201064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of chiral MS-245 analogs at h5-HT6 receptors.
    Abate C; Kolanos R; Dukat M; Setola V; Roth BL; Glennon RA
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3510-3. PubMed ID: 15990303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N1-(Benzenesulfonyl)tryptamines as novel 5-HT6 antagonists.
    Tsai Y; Dukat M; Slassi A; MacLean N; Demchyshyn L; Savage JE; Roth BL; Hufesein S; Lee M; Glennon RA
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2295-9. PubMed ID: 11055342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of N1-unsubstituted and N1-benzenesulfonyltryptamines at h5-HT6 receptors.
    Kolanos R; Dukat M; Roth BL; Glennon RA
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5832-5. PubMed ID: 16945532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular modeling of the dopamine D2 and serotonin 5-HT1A receptor binding modes of the enantiomers of 5-OMe-BPAT.
    Homan EJ; Wikström HV; Grol CJ
    Bioorg Med Chem; 1999 Sep; 7(9):1805-20. PubMed ID: 10530928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The medicinal chemistry of 5-HT6 receptor ligands with a focus on arylsulfonyltryptamine analogs.
    Glennon RA; Siripurapu U; Roth BL; Kolanos R; Bondarev ML; Sikazwe D; Lee M; Dukat M
    Curr Top Med Chem; 2010; 10(5):579-95. PubMed ID: 20166945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential modes of agonist binding to 5-hydroxytryptamine(2A) serotonin receptors revealed by mutation and molecular modeling of conserved residues in transmembrane region 5.
    Shapiro DA; Kristiansen K; Kroeze WK; Roth BL
    Mol Pharmacol; 2000 Nov; 58(5):877-86. PubMed ID: 11040033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of tryptamine and ergoline compounds with threonine 196 in the ligand binding site of the 5-hydroxytryptamine6 receptor.
    Boess FG; Monsma FJ; Meyer V; Zwingelstein C; Sleight AJ
    Mol Pharmacol; 1997 Sep; 52(3):515-23. PubMed ID: 9284367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformationally constrained N1-arylsulfonyltryptamine derivatives as 5-HT6 receptor antagonists.
    Cole DC; Lennox WJ; Stock JR; Ellingboe JW; Mazandarani H; Smith DL; Zhang G; Tawa GJ; Schechter LE
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4780-5. PubMed ID: 16125933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of tryptamine analogs at h5-HT1E receptors: a structure-affinity investigation.
    Dukat M; Smith C; Herrick-Davis K; Teitler M; Glennon RA
    Bioorg Med Chem; 2004 May; 12(10):2545-52. PubMed ID: 15110837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further studies on the binding of N1-substituted tryptamines at h5-HT6 receptors.
    Nyandege A; Kolanos R; Roth BL; Glennon RA
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1691-4. PubMed ID: 17239595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of ligand SAR, receptor modeling and receptor mutagenesis to the discovery and development of a new class of 5-HT(2A) ligands.
    Westkaemper RB; Glennon RA
    Curr Top Med Chem; 2002 Jun; 2(6):575-98. PubMed ID: 12052195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rigidized 1-aryl sulfonyl tryptamines: synthesis and pharmacological evaluation as 5-HT6 receptor ligands.
    Nirogi R; Dwarampudi A; Kambhampati R; Bhatta V; Kota L; Shinde A; Badange R; Jayarajan P; Bhyrapuneni G; Dubey PK
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4577-80. PubMed ID: 21724392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of novel series of 5-HT6 receptor ligands having indole, a central aromatic core and 1-amino-4 methyl piperazine as a positive ionizable group.
    Hayat F; Cho S; Rhim H; Indu Viswanath AN; Pae AN; Lee JY; Choo DJ; Choo HY
    Bioorg Med Chem; 2013 Sep; 21(17):5573-82. PubMed ID: 23810425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the 5-HT(7) receptor. Determination of the pharmacophore for 5-HT(7) receptor agonism and CoMFA-based modeling of the agonist binding site.
    Vermeulen ES; Schmidt AW; Sprouse JS; Wikström HV; Grol CJ
    J Med Chem; 2003 Dec; 46(25):5365-74. PubMed ID: 14640545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole spectrum analysis of ligand efficacy at constitutively active human wild-type and S267K 5-HT6 receptors in HEK-293F cells.
    Romero G; Pujol M; Pérez P; Buschmann H; Pauwels PJ
    J Pharmacol Toxicol Methods; 2007; 55(2):144-50. PubMed ID: 16769227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacophore-directed homology modeling and molecular dynamics simulation of G protein-coupled receptor: study of possible binding modes of 5-HT2C receptor agonists.
    Zuo Z; Chen G; Luo X; Puah C; Zhu W; Chen K; Jiang H
    Acta Biochim Biophys Sin (Shanghai); 2007 Jun; 39(6):413-22. PubMed ID: 17558446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A highly conserved aspartic acid (Asp-155) anchors the terminal amine moiety of tryptamines and is involved in membrane targeting of the 5-HT(2A) serotonin receptor but does not participate in activation via a "salt-bridge disruption" mechanism.
    Kristiansen K; Kroeze WK; Willins DL; Gelber EI; Savage JE; Glennon RA; Roth BL
    J Pharmacol Exp Ther; 2000 Jun; 293(3):735-46. PubMed ID: 10869371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational model of the complex between GR113808 and the 5-HT4 receptor guided by site-directed mutagenesis and the crystal structure of rhodopsin.
    López-Rodríguez ML; Murcia M; Benhamú B; Olivella M; Campillo M; Pardo L
    J Comput Aided Mol Des; 2001 Nov; 15(11):1025-33. PubMed ID: 11989623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward selective drug development for the human 5-hydroxytryptamine 1E receptor: a comparison of 5-hydroxytryptamine 1E and 1F receptor structure-affinity relationships.
    Klein MT; Dukat M; Glennon RA; Teitler M
    J Pharmacol Exp Ther; 2011 Jun; 337(3):860-7. PubMed ID: 21422162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.